Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 4;12(7):1765–1786. doi: 10.21037/tcr-23-34

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2023 Translational Cancer Research. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

PMC Copyright notice

Prognostic significance of CIAPIN1 expression in various subgroups of IBC patients. (A-F) DSS survival curves of IBC subjects with high and reduced CIAPIN1 expression at N1&N2&N3 stage, pathologic stage II&III&IV, age >60 years, white, postmenopausal and left subgroup of tumor anatomy. (G-M) PFI survival curves of T3&T4, N1&N2&N3, age >60 years, White, post menopause status, anatomic neoplasm subdivision-left, and non-radiotherapy subgroups of IBC patients with high and low CIAPIN1 expression. CIAPIN1, cytokine-induced apoptosis inhibitor 1; IBC, invasive breast cancer; DSS, disease specific survival; PFI, progress free interval; HR, hazard ratio.